Yayın:
Pesg PNH diagnosis, follow-up and treatment guidelines

dc.contributor.authorŞahin, Fahri
dc.contributor.authorAkay, Olga Meltem
dc.contributor.authorAyer, Mesut
dc.contributor.authorDal, Mehmet Sinan
dc.contributor.authorErtop, Sehmus
dc.contributor.authorİlhan, Osman
dc.contributor.authorKarakuş, Volkan
dc.contributor.authorÖzcan, Mehmet Ali
dc.contributor.authorÖzkocaman, Vildan
dc.contributor.authorÖzsan, Hayri
dc.contributor.authorSalim, Ozan
dc.contributor.authorTobu, Mahmut
dc.contributor.authorTombak, Anıl
dc.contributor.authorTuğlular, Tülin Fıratlı
dc.contributor.authorYılmaz, Mehmet
dc.contributor.authorÜnal, Ali
dc.contributor.authorYenerel, Mustafa Nuri
dc.contributor.authorSaydam, Güray
dc.contributor.buuauthorÖZKOCAMAN, VİLDAN
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentHematoloji Bölümü
dc.contributor.researcheridAAH-1854-2021
dc.date.accessioned2024-11-19T05:21:02Z
dc.date.available2024-11-19T05:21:02Z
dc.date.issued2016-01-01
dc.description.abstractPNH Education and Study Group ( PESG) have been established in December 2013 as a non-profit, independent, medical organization www.pesg.org. Paroxysmal Nocturnal Hemoglobinuria ( PNH) is a multi-systemic disease that should be treated with a multidisciplinary approach. Patients may apply to the clinics other than the hematology due to variability and diversity of clinical findings which lower the rate of diagnosis due to low awareness about PNH. PNH might be overlooked and diagnosis might be delayed. Regarding these, PESG was established with the collaboration of Immunology, Cardiology, Thorax Diseases ( Pulmonology), Neurology, Gastroenterology, General Surgery and Urology specialists in addition to hematologists dealing with PNH. The PESG study group aims to increase the awareness about PNH, including training activities about PNH, strengthening the relations between clinics and planning of clinical studies as a goal. It is the first professional organization focusing on PNH, in Turkey. In this guideline, we want to facilitate the diagnosis attributes of physicians from all specializations that deal with PNH and its systemic complications. One can perceive this as a tailor made guideline of international guidelines but not a compilation.
dc.identifier.endpage27
dc.identifier.issn2160-1992
dc.identifier.issue2
dc.identifier.startpage19
dc.identifier.urihttps://hdl.handle.net/11452/48032
dc.identifier.volume6
dc.identifier.wos000388367600001
dc.indexed.wosWOS.ESCI
dc.language.isoen
dc.publisherE-century Publishing Corp
dc.relation.journalAmerican Journal of Blood Research
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectParoxysmal-nocturnal hemoglobinuria
dc.subjectComplement inhibitor eculizumab
dc.subjectStem-cell transplantation
dc.subjectClinical management
dc.subjectNatural-history
dc.subjectThromboembolism
dc.subjectPrevalence
dc.subjectThrombosis
dc.subjectPregnancy
dc.subjectDisease
dc.subjectPNH
dc.subjectGuideline
dc.subjectDiagnosis
dc.subjectTreatment
dc.subjectScience & technology
dc.subjectLife sciences & biomedicine
dc.subjectMedicine, research & experimental
dc.subjectResearch & experimental medicine
dc.titlePesg PNH diagnosis, follow-up and treatment guidelines
dc.typeReview
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Hematoloji Bölümü
local.indexed.atWOS
relation.isAuthorOfPublication516d4442-e436-45a6-87b9-741a9e213d31
relation.isAuthorOfPublication.latestForDiscovery516d4442-e436-45a6-87b9-741a9e213d31

Dosyalar